Dr Sylvie Bonvalot talks with ecancer at the 2012 ESMO meeting in Vienna about the strategy of treatment for desmoid tumours.

Desmoid tumours, a rare type of aggressive tumour, can present in almost any part of the body.

The most important part of diagnosis for this tumour type is testing for a beta kinase mutation that 95% of patients have. 

The main advances come specifically in altering strategy on approaching treatment as half of patients receiving treatment cannot continue after the first course because of adverse side effects.

Filming supported by Amgen